Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Sivelestat Sodium Hydrate in Acute Lung Injury Associated With Systemic Inflammatory Response Syndrome, Compared With the Conventional Treatment in Japan

NCT00219375 is registered in ClinicalTrials.gov with Ono Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT00219375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00219375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Sivelestat Sodium Hydrate in Acute Lung Injury Associated With Systemic Inflammatory Response Syndrome, Compared With the Conventional Treatment in Japan
Lead sponsor
Ono Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2004
Completion date
Not reported
Enrollment
649 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury, systemic inflammatory response syndrome